STERIS plc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Mar 31, 2026 · FY), STERIS plc reported revenue of $5.9B (+8.7% year on year) and net income of $785.1M (+27.4% year on year).
| Line item | Mar 31, 2026 · FY | Mar 31, 2025 · FY | Mar 31, 2024 · FY | Mar 31, 2023 · FY |
|---|---|---|---|---|
| Total revenues | $5.9B | $5.5B | $5.1B | $5.0B |
| Cost of revenues | $3.3B | $3.1B | $2.9B | $2.8B |
| Gross Profit | $2.6B | $2.4B | $2.2B | $2.2B |
| Selling, general, and administrative | $1.4B | $1.3B | $1.3B | $1.3B |
| Research and development | $112.9M | $107.6M | $103.7M | $101.6M |
| Litigation Settlement, Loss | $0 | $48.1M | — | — |
| Restructuring Costs | $4.1M | $46.0M | $26.0M | $485.0K |
| Total operating expenses | $1.5B | $1.5B | $1.4B | $1.9B |
| Income (loss) from operations | $1.1B | $866.6M | $836.1M | $268.2M |
| Interest expense | $60.7M | $86.3M | $144.4M | $108.0M |
| Interest income and miscellaneous expense | ($9.8M) | ($8.4M) | ($11.0M) | $2.8M |
| Other expense (income), net | ($3.5M) | $7.4M | — | — |
| Total non-operating expenses, net | $54.4M | $70.4M | $133.3M | $110.8M |
| Income (loss) before income tax expense (benefit) | $1.0B | $796.2M | $702.8M | $157.3M |
| Income tax expense (benefit) | $262.2M | $184.7M | $149.5M | $51.5M |
| Income from continuing operations, net of income tax | $785.1M | $611.6M | $553.3M | — |
| Income (loss) from discontinued operations, net of income tax | $0 | $4.5M | ($173.2M) | — |
| Net income | $785.1M | $616.1M | $380.1M | $105.8M |
| Less: Net income attributable to noncontrolling interests | $2.8M | $1.4M | $1.8M | ($1.2M) |
| Net income attributable to shareholders | $782.3M | $614.6M | $378.2M | $107.0M |
| Income (Loss) from Continuing Operations, Per Basic Share | $7.97 | $6.19 | $5.58 | — |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | $0 | $0.05 | ($1.75) | — |
| Earnings Per Share, Basic | $7.97 | $6.24 | $3.83 | $1.07 |
| Income (Loss) from Continuing Operations, Per Diluted Share | $7.93 | $6.16 | $5.55 | — |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | $0 | $0.05 | ($1.74) | — |
| Earnings Per Share, Diluted | $7.93 | $6.20 | $3.81 | $1.07 |
| Cash dividends declared per common share outstanding | $2.46 | $2.23 | $2.03 | $1.84 |
| Line item | Jun 30, 2026 · Q1 | Dec 31, 2025 · Q3 | Sep 30, 2025 · Q2 | Jun 30, 2025 · Q1 |
|---|---|---|---|---|
| Revenues | $1.5B | $1.5B | $1.5B | $1.4B |
| Cost of Product and Service Sold | $808.5M | $840.7M | $814.4M | $763.1M |
| Total cost of revenues | $808.6M | $840.7M | $814.4M | $763.1M |
| Gross Profit | $684.2M | $655.5M | $645.9M | $628.0M |
| Selling, general, and administrative | $369.7M | $352.3M | $349.7M | $353.8M |
| Research and development | $28.6M | $29.5M | $28.2M | $26.4M |
| Restructuring Costs | $0 | $400.0K | $2.2M | $1.8M |
| Total operating expenses | $398.3M | $382.3M | $380.1M | $382.0M |
| Income from operations | $285.8M | $273.2M | $265.8M | $246.0M |
| Interest expense | $15.8M | $14.9M | $14.9M | $15.9M |
| Interest income and miscellaneous expense | ($3.1M) | ($2.9M) | ($2.4M) | ($1.8M) |
| Other income, net | ($300.0K) | $3.3M | — | — |
| Total non-operating expenses, net | $12.3M | $15.3M | $12.7M | $14.1M |
| Income before income tax expense | $273.5M | $257.8M | $253.1M | $231.9M |
| Income tax expense | $72.5M | $63.5M | $60.6M | $53.9M |
| Net income | $201.0M | $194.3M | $192.5M | $178.0M |
| Less: Net Income Attributable to Noncontrolling Interest | $900.0K | $1.5M | $600.0K | $600.0K |
| Net Income (Loss) Attributable to Shareholders | $200.1M | $192.9M | $191.9M | $177.4M |
| Income (Loss) from Continuing Operations, Per Basic Share | $2.05 | $1.96 | $1.95 | $1.8 |
| Income (Loss) from Continuing Operations, Per Diluted Share | $2.04 | $1.96 | $1.94 | $1.79 |
| Cash dividends declared per common share outstanding | $0.63 | $0.63 | $0.63 | $0.57 |
| Line item | Mar 31, 2026 · FY | Mar 31, 2025 · FY | Mar 31, 2024 · FY | Mar 31, 2023 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $439.6M | $171.7M | $207.0M | $208.4M |
| Accounts receivable (net of allowances of $24,354 and $22,984, respectively) | $1.1B | $1.0B | $1.0B | $928.3M |
| Inventories, net | $631.8M | $581.3M | $674.5M | $695.5M |
| Prepaid expenses and other current assets | $230.4M | $203.8M | $174.3M | $179.3M |
| Total current assets | $2.4B | $2.0B | $2.9B | $2.0B |
| Property, plant, and equipment, net | $2.2B | $2.0B | $1.8B | $1.7B |
| Operating Lease, Right-of-Use Asset | $155.2M | $156.4M | $173.2M | $191.7M |
| Goodwill | $4.2B | $4.1B | $4.1B | $3.9B |
| Intangible Asset, Excluding Goodwill, after Accumulated Amortization | $1.6B | $1.9B | $2.1B | $3.0B |
| Other assets | $211.4M | $83.0M | $66.2M | $78.1M |
| Assets | $10.7B | $10.1B | $11.1B | $10.8B |
| Accounts payable | $338.8M | $280.8M | $251.7M | $279.6M |
| Accrued Income Taxes, Current | $28.6M | $21.5M | $13.6M | $43.8M |
| Accrued payroll and other related liabilities | $221.1M | $192.7M | $164.8M | $125.6M |
| Capital Lease Obligations, Current | $35.8M | $34.2M | $31.2M | $35.0M |
| Short-term Debt | $118.9M | $125.0M | $85.9M | $60.0M |
| Accrued expenses and other | $401.9M | $368.1M | $319.7M | $317.8M |
| Total current liabilities | $1.1B | $1.0B | $931.1M | $861.8M |
| Long-term indebtedness | $1.8B | $1.9B | $3.1B | $3.0B |
| Deferred income taxes, net | $390.7M | $403.7M | $479.7M | $617.5M |
| Capital Lease Obligations, Noncurrent | $119.6M | $124.6M | $145.8M | $160.5M |
| Other Liabilities, Noncurrent | $71.7M | $61.9M | $71.5M | $76.1M |
| Total liabilities | $3.5B | $3.5B | $4.7B | $4.7B |
| Ordinary shares, with $0.001 par value; 500,000 shares authorized; 98,301 and 98,883 ordinary shares issued and outstanding, respectively | 4.3B | 4.4B | 4.5B | 4.5B |
| Retained earnings | $3.0B | $2.5B | $2.1B | $1.9B |
| Accumulated other comprehensive income | ($113.1M) | ($292.3M) | ($328.7M) | ($320.7M) |
| Total shareholders' equity | $7.2B | $6.6B | $6.3B | $6.1B |
| Noncontrolling interest | $13.6M | $12.4M | $13.2M | $10.0M |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $7.2B | $6.6B | $6.3B | $6.1B |
| Total liabilities and equity | $10.7B | $10.1B | $11.1B | $10.8B |
| Line item | Jun 30, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $482.3M | $423.7M | $319.2M | $279.7M |
| Accounts receivable (net of allowances of $25.6 and $24.4, respectively) | $1.0B | $990.6M | $947.3M | $947.1M |
| Inventories, net | $712.1M | $673.5M | $658.5M | $641.2M |
| Prepaid expenses and other current assets | $238.2M | $198.4M | $181.3M | $189.8M |
| Total current assets | $2.4B | $2.3B | $2.1B | $2.1B |
| Property, plant, and equipment, net | $2.2B | $2.1B | $2.1B | $2.1B |
| Lease right-of-use assets, net | $150.8M | $154.9M | $160.6M | $163.5M |
| Goodwill | $4.2B | $4.2B | $4.2B | $4.2B |
| Intangible Asset, Excluding Goodwill, after Accumulated Amortization | $1.6B | $1.7B | $1.7B | $1.8B |
| Other assets | $215.1M | $93.6M | $87.9M | $88.6M |
| Total assets | $10.7B | $10.6B | $10.4B | $10.4B |
| Accounts payable | $344.1M | $285.1M | $308.9M | $300.9M |
| Accrued income taxes | $86.5M | $9.9M | $16.9M | $64.7M |
| Accrued payroll and other related liabilities | $153.1M | $188.0M | $167.5M | $154.7M |
| Capital Lease Obligations, Current | $35.6M | $34.4M | $35.3M | $35.3M |
| Short-term Debt | $243.4M | $0 | $0 | $0 |
| Accrued expenses and other | $420.5M | $405.0M | $360.3M | $371.0M |
| Total current liabilities | $1.3B | $922.3M | $888.9M | $926.6M |
| Long-term indebtedness | $1.7B | $1.9B | $1.9B | $1.9B |
| Deferred Income Taxes and Other Tax Liabilities, Noncurrent | $390.8M | $414.5M | $412.0M | $411.4M |
| Capital Lease Obligations, Noncurrent | $115.3M | $120.9M | $126.0M | $130.4M |
| Other Liabilities, Noncurrent | $75.2M | $67.4M | $63.9M | $63.6M |
| Total liabilities | $3.5B | $3.4B | $3.4B | $3.4B |
| Ordinary shares, with $0.001 par value; 500.0 shares authorized; 98.5 and 98.3 ordinary shares issued and outstanding, respectively | 4.2B | 4.3B | 4.4B | 4.4B |
| Retained earnings | $3.2B | $2.9B | $2.7B | $2.6B |
| Accumulated other comprehensive income | ($127.3M) | ($42.7M) | ($76.1M) | ($70.5M) |
| Total shareholders' equity | $7.2B | $7.2B | $7.0B | $7.0B |
| Noncontrolling interest | $14.5M | $13.4M | $13.5M | $12.9M |
| Total equity | $7.2B | $7.2B | $7.0B | $7.0B |
| Total liabilities and equity | $10.7B | $10.6B | $10.4B | $10.4B |
| Line item | Mar 31, 2026 · FY | Mar 31, 2025 · FY | Mar 31, 2024 · FY | Mar 31, 2023 · FY |
|---|---|---|---|---|
| Income from continuing operations, net of income tax | $785.1M | $616.1M | $380.1M | $105.8M |
| Depreciation, depletion, and amortization | $486.5M | $476.2M | $565.2M | $552.9M |
| Deferred income taxes | ($16.9M) | ($76.5M) | ($131.4M) | ($185.9M) |
| Share-based compensation | $61.7M | $57.4M | $56.5M | $39.0M |
| Loss on the disposal of property, plant, equipment, and intangibles, net | $3.6M | $5.7M | $25.0M | $22.2M |
| Loss on classification as held for sale | $0 | $0 | $206.4M | — |
| Gain (Loss) on Disposition of Business And Equity Investments, Net | ($300.0K) | $6.4M | — | — |
| Amortization of inventory fair value adjustments | $0 | $0 | $4.8M | $7.4M |
| Other items | ($5.6M) | ($3.7M) | $12.3M | ($24.8M) |
| Accounts receivable, net | ($25.1M) | ($28.8M) | ($128.1M) | ($133.3M) |
| Inventories, net | ($24.0M) | $73.1M | ($37.5M) | ($123.9M) |
| Other current assets | ($22.7M) | ($50.3M) | ($1.6M) | ($24.1M) |
| Accounts payable | $51.1M | $33.6M | ($19.0M) | $53.3M |
| Accruals and other, net | $47.8M | $38.9M | $40.0M | ($22.1M) |
| Net cash provided by operating activities | $1.3B | $1.1B | $973.3M | $756.9M |
| Purchases of property, plant, equipment, and intangibles, net | ($369.0M) | ($370.1M) | ($360.3M) | ($362.0M) |
| Proceeds from the sale of property, plant, equipment, and intangibles | $10.5M | $9.2M | $7.4M | $14.6M |
| Proceeds from Divestiture of Businesses | $0 | $814.6M | $9.5M | $6.6M |
| Proceeds from Sale of Other Investments | $0 | $0 | $3.9M | — |
| Payments to Acquire Investments | ($134.0M) | ($10.8M) | ($1.5M) | $0 |
| Investments in businesses, net of cash acquired | ($20.1M) | ($54.1M) | ($546.3M) | ($42.6M) |
| Net cash used in investing activities | ($512.5M) | $388.8M | ($887.4M) | ($383.3M) |
| Repayments of Secured Debt | $0 | ($638.1M) | ($60.0M) | ($156.9M) |
| Payments for Repurchase of Private Placement | ($125.0M) | ($80.0M) | $0 | — |
| Proceeds Under Credit Facility, net | $3.0M | ($446.3M) | $181.5M | $241.7M |
| Amortization of Financing Costs | $0 | ($2.3M) | $0 | $0 |
| Payments of Merger Related Costs, Financing Activities | ($400.0K) | ($355.0K) | ($6.2M) | ($1.5M) |
| Repurchases of ordinary shares | -235.5M | -211.3M | -11.8M | -308.6M |
| Cash dividends paid to common shareholders | ($241.8M) | ($219.9M) | ($200.6M) | ($183.5M) |
| Payments to Noncontrolling Interests | ($1.4M) | ($2.1M) | ($1.6M) | ($794.0K) |
| Proceeds from Noncontrolling Interests | $0 | $2.5M | $3.0M | $0 |
| Proceeds from (Payment for) Other Financing Activity | $32.9M | $25.5M | $10.5M | $1.8M |
| Net cash (used in) provided by financing activities | ($568.2M) | ($1.6B) | ($85.2M) | ($498.7M) |
| Effect of exchange rate changes on cash and cash equivalents | $7.2M | $185.0K | ($2.1M) | ($14.9M) |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $267.9M | ($35.3M) | ($1.3M) | ($140.0M) |
| Cash and cash equivalents at beginning of period | $171.7M | $207.0M | $208.4M | $348.3M |
| Cash and cash equivalents at end of period | $439.6M | $171.7M | $207.0M | $208.4M |
| Line item | Jun 30, 2026 · Q1 | Dec 31, 2025 · YTD | Sep 30, 2025 · YTD | Jun 30, 2025 · Q1 |
|---|---|---|---|---|
| Net Income | $201.0M | $564.8M | $370.4M | $178.0M |
| Depreciation, depletion, and amortization | $123.8M | $363.1M | $241.1M | $119.4M |
| Deferred income taxes | $600.0K | ($200.0K) | ($100.0K) | $0 |
| Share-based compensation expense | $12.8M | $48.8M | $33.1M | $11.9M |
| Other items | $11.2M | $12.2M | $13.2M | $14.5M |
| Accounts receivable, net | $90.0M | $98.4M | $113.9M | $119.2M |
| Inventories, net | ($73.3M) | ($62.5M) | ($60.7M) | ($42.5M) |
| Other current assets | ($8.0M) | $10.0M | $25.5M | $18.9M |
| Accounts payable | $4.3M | ($5.8M) | $23.0M | $9.8M |
| Accruals and other, net | $4.8M | ($26.5M) | ($52.1M) | ($9.2M) |
| Net cash provided by operating activities | $367.1M | $1.0B | $707.8M | $420.0M |
| Purchases of property, plant, equipment, and intangibles | ($87.5M) | ($278.8M) | ($180.1M) | ($93.6M) |
| Proceeds from the sale of property, plant, equipment, and intangibles | $0 | $10.4M | — | $100.0K |
| Purchase of investments | ($5.0M) | ($6.8M) | ($1.8M) | — |
| Acquisition of businesses, net of cash acquired | ($16.0M) | ($20.1M) | ($15.0M) | ($15.0M) |
| Net cash used in investing activities | ($108.5M) | ($295.3M) | ($196.8M) | ($108.5M) |
| Payments on Private Placement Senior Notes | $0 | ($125.0M) | ($125.0M) | ($125.0M) |
| Payments under credit facilities, net | ($37.8M) | ($34.8M) | ($34.8M) | ($30.5M) |
| Acquisition related deferred or contingent consideration | ($100.0K) | ($300.0K) | ($200.0K) | ($100.0K) |
| Repurchases of ordinary shares | -115.5M | -161.2M | -111.1M | -10.6M |
| Cash dividends paid to ordinary shareholders | ($61.4M) | ($180.0M) | ($118.1M) | ($56.2M) |
| Stock option and other equity transactions, net | $1.3M | $32.3M | $16.9M | $9.3M |
| Net cash used in financing activities | ($213.5M) | ($470.3M) | ($372.3M) | ($213.1M) |
| Effect of exchange rate changes on cash and cash equivalents | ($2.3M) | $11.6M | $8.7M | $9.6M |
| Increase in cash and cash equivalents | $42.8M | $252.0M | $147.5M | $108.0M |
| Cash and cash equivalents at beginning of period | $439.6M | $171.7M | $319.2M | $279.7M |
| Cash and cash equivalents at end of period | $482.3M | $423.7M | — | — |
STERIS plc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.